{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T22:28:25Z","timestamp":1794608905697,"version":"4.9.1"},"posted":{"date-parts":[[2026,9,29]]},"group-title":"In Review","reference-count":52,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:00:00Z","timestamp":1790640000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2026,9,2]]},"abstract":"<title>Abstract<\/title>\n                <p>Exercise\u2019s effect on Dox-induced cardiac senescence in the heart was investigated using p16-3MR transgenic mice. Mice treated with doxorubicin (Dox) had decreased cardiac function, increased p16INK4a\u2009+\u2009and b-Galactosidase+ senescent cells in the heart, decreased HMGB1 and calreticulin expression, endothelial cell senescence, and decreased TUJ1 expression (indicating reduced axonal density), increased expression of Semaphorin3A and p-cofilin with impaired F-actin depolarization and cytoskeleton disorganization. None of these changes were seen in mice treated with Dox\u2009+\u2009Exercise. Exercise sustained the levels of FNDC5 in the heart compared with the Dox-treated hearts suggesting a link between exercise, decreased senescence, and the FNDC5\/ irisin pathway. In vitro studies using human cardiomyocytes and endothelial cells confirmed that irisin attenuated Dox-induced senescence. Taken together, these data provide evidence that exercise mitigates Dox-induced cardiotoxicity by suppressing cardiovascular senescence via a mechanism involving the exercise-induced myosin irisin, and that exercise is a potential intervention for preventing Dox-induced cardiotoxicity.<\/p>","DOI":"10.21203\/rs.3.rs-10910107\/v1","type":"posted-content","created":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T13:56:12Z","timestamp":1790690172000},"source":"Crossref","is-referenced-by-count":0,"title":["Exercise inhibits doxorubicin-induced cardiotoxicity by preventing cardiac and endothelial cell senescence by activating FNDC5\/Irisin signaling"],"prefix":"10.21203","author":[{"given":"Prince","family":"Jeyabal","sequence":"first","affiliation":[{"name":"The University of Texas MD Anderson Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pradeep","family":"Shrestha","sequence":"additional","affiliation":[{"name":"The University of Texas MD Anderson Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanzheng","family":"Yang","sequence":"additional","affiliation":[{"name":"The University of Texas MD Anderson Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Wang","sequence":"additional","affiliation":[{"name":"The University of Texas MD Anderson Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhanglong","family":"Peng","sequence":"additional","affiliation":[{"name":"The University of Texas MD Anderson Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"You","family":"Zhou","sequence":"additional","affiliation":[{"name":"The University of Texas MD Anderson Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zheng","sequence":"additional","affiliation":[{"name":"The University of Texas MD Anderson Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenie S.","family":"Kleinerman","sequence":"additional","affiliation":[{"name":"The University of Texas MD Anderson Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"R741","DOI":"10.1016\/j.cub.2012.07.024","article-title":"Ageing as a risk factor for disease","volume":"22","author":"Niccoli T","year":"2012","unstructured":"Niccoli, T. & Partridge, L. Ageing as a risk factor for disease. Curr Biol 22, R741\u2013752 (2012). https:\/\/doi.org\/10.1016\/j.cub.2012.07.024","journal-title":"Curr Biol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"e153","DOI":"10.1161\/CIR.0000000000001052","article-title":"Heart Disease and Stroke Statistics-2022 Update: A Report From the American Heart Association","volume":"145","author":"Tsao CW","year":"2022","unstructured":"Tsao, C. W. et al. Heart Disease and Stroke Statistics-2022 Update: A Report From the American Heart Association. Circulation 145, e153\u2013e639 (2022). https:\/\/doi.org\/10.1161\/CIR.0000000000001052","journal-title":"Circulation"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1016\/S1470-2045(16)30215-7","article-title":"Cumulative burden of cardiovascular morbidity in paediatric, adolescent, and young adult survivors of Hodgkin's lymphoma: an analysis from the St Jude Lifetime Cohort Study","volume":"17","author":"Bhakta N","year":"2016","unstructured":"Bhakta, N. et al. Cumulative burden of cardiovascular morbidity in paediatric, adolescent, and young adult survivors of Hodgkin's lymphoma: an analysis from the St Jude Lifetime Cohort Study. Lancet Oncol 17, 1325\u20131334 (2016). https:\/\/doi.org\/10.1016\/S1470-2045(16)30215-7","journal-title":"Lancet Oncol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"e108","DOI":"10.1016\/S1470-2045(23)00012-8","article-title":"Systematic review and updated recommendations for cardiomyopathy surveillance for survivors of childhood, adolescent, and young adult cancer from the International Late Effects of Childhood Cancer Guideline Harmonization Group","volume":"24","author":"Ehrhardt MJ","year":"2023","unstructured":"Ehrhardt, M. J. et al. Systematic review and updated recommendations for cardiomyopathy surveillance for survivors of childhood, adolescent, and young adult cancer from the International Late Effects of Childhood Cancer Guideline Harmonization Group. Lancet Oncol 24, e108\u2013e120 (2023). https:\/\/doi.org\/10.1016\/S1470-2045(23)00012-8","journal-title":"Lancet Oncol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1097\/CRD.0000000000000194","article-title":"Cardioprotection in the Modern Era of Cancer Chemotherapy","volume":"26","author":"Godishala A","year":"2018","unstructured":"Godishala, A., Yang, S. & Asnani, A. Cardioprotection in the Modern Era of Cancer Chemotherapy. Cardiol Rev 26, 113\u2013121 (2018). https:\/\/doi.org\/10.1097\/CRD.0000000000000194","journal-title":"Cardiol Rev"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1161\/CIRCULATIONAHA.114.013777","article-title":"Early detection of anthracycline cardiotoxicity and improvement with heart failure therapy","volume":"131","author":"Cardinale D","year":"2015","unstructured":"Cardinale, D. et al. Early detection of anthracycline cardiotoxicity and improvement with heart failure therapy. Circulation 131, 1981\u20131988 (2015). https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.114.013777","journal-title":"Circulation"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"H448","DOI":"10.1152\/ajpheart.00287.2018","article-title":"Cellular senescence links aging and diabetes in cardiovascular disease","volume":"315","author":"Shakeri H","year":"2018","unstructured":"Shakeri, H., Lemmens, K., Gevaert, A. B., De Meyer, G. R. Y. & Segers, V. F. M. Cellular senescence links aging and diabetes in cardiovascular disease. Am J Physiol Heart Circ Physiol 315, H448\u2013H462 (2018). https:\/\/doi.org\/10.1152\/ajpheart.00287.2018","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1038\/s42255-021-00483-8","article-title":"The metabolic roots of senescence: mechanisms and opportunities for intervention","volume":"3","author":"Wiley CD","year":"2021","unstructured":"Wiley, C. D. & Campisi, J. The metabolic roots of senescence: mechanisms and opportunities for intervention. Nat Metab 3, 1290\u20131301 (2021). https:\/\/doi.org\/10.1038\/s42255-021-00483-8","journal-title":"Nat Metab"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3390\/cells12091296","article-title":"Senescent Cells: A Therapeutic Target in Cardiovascular Diseases","volume":"12","author":"Suda M","year":"2023","unstructured":"Suda, M. et al. Senescent Cells: A Therapeutic Target in Cardiovascular Diseases. Cells 12 (2023). https:\/\/doi.org\/10.3390\/cells12091296","journal-title":"Cells"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1161\/CIRCRESAHA.119.315889","article-title":"Targeting Age-Related Pathways in Heart Failure","volume":"126","author":"Li H","year":"2020","unstructured":"Li, H. et al. Targeting Age-Related Pathways in Heart Failure. Circ Res 126, 533\u2013551 (2020). https:\/\/doi.org\/10.1161\/CIRCRESAHA.119.315889","journal-title":"Circ Res"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/s41581-022-00601-z","article-title":"Cellular senescence: the good, the bad and the unknown","volume":"18","author":"Huang W","year":"2022","unstructured":"Huang, W., Hickson, L. J., Eirin, A., Kirkland, J. L. & Lerman, L. O. Cellular senescence: the good, the bad and the unknown. Nat Rev Nephrol 18, 611\u2013627 (2022). https:\/\/doi.org\/10.1038\/s41581-022-00601-z","journal-title":"Nat Rev Nephrol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1158\/2159-8290.CD-16-0241","article-title":"Cellular Senescence Promotes Adverse Effects of Chemotherapy and Cancer Relapse","volume":"7","author":"Demaria M","year":"2017","unstructured":"Demaria, M. et al. Cellular Senescence Promotes Adverse Effects of Chemotherapy and Cancer Relapse. Cancer Discov 7, 165\u2013176 (2017). https:\/\/doi.org\/10.1158\/2159-8290.CD-16-0241","journal-title":"Cancer Discov"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"C380","DOI":"10.1152\/ajpcell.00073.2019","article-title":"Accelerated cardiomyocyte senescence contributes to late-onset doxorubicin-induced cardiotoxicity","volume":"318","author":"Mitry MA","year":"2020","unstructured":"Mitry, M. A. et al. Accelerated cardiomyocyte senescence contributes to late-onset doxorubicin-induced cardiotoxicity. Am J Physiol Cell Physiol 318, C380\u2013C391 (2020). https:\/\/doi.org\/10.1152\/ajpcell.00073.2019","journal-title":"Am J Physiol Cell Physiol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"e12931","DOI":"10.1111\/acel.12931","article-title":"Aged-senescent cells contribute to impaired heart regeneration","volume":"18","author":"Lewis-McDougall FC","year":"2019","unstructured":"Lewis-McDougall, F. C. et al. Aged-senescent cells contribute to impaired heart regeneration. Aging Cell 18, e12931 (2019). https:\/\/doi.org\/10.1111\/acel.12931","journal-title":"Aging Cell"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s41514-023-00113-5","article-title":"Senescent cardiomyocytes contribute to cardiac dysfunction following myocardial infarction","volume":"9","author":"Redgrave RE","year":"2023","unstructured":"Redgrave, R. E. et al. Senescent cardiomyocytes contribute to cardiac dysfunction following myocardial infarction. NPJ Aging 9, 15 (2023). https:\/\/doi.org\/10.1038\/s41514-023-00113-5","journal-title":"NPJ Aging"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.jaccao.2020.06.010","article-title":"Doxorubicin-Induced Oxidative Stress and Endothelial Dysfunction in Conduit Arteries Is Prevented by Mitochondrial-Specific Antioxidant Treatment","volume":"2","author":"Clayton ZS","year":"2020","unstructured":"Clayton, Z. S. et al. Doxorubicin-Induced Oxidative Stress and Endothelial Dysfunction in Conduit Arteries Is Prevented by Mitochondrial-Specific Antioxidant Treatment. JACC CardioOncol 2, 475\u2013488 (2020). https:\/\/doi.org\/10.1016\/j.jaccao.2020.06.010","journal-title":"JACC CardioOncol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/s41392-023-01502-8","article-title":"Inflammation and aging: signaling pathways and intervention therapies","volume":"8","author":"Li X","year":"2023","unstructured":"Li, X. et al. Inflammation and aging: signaling pathways and intervention therapies. Signal Transduct Target Ther 8, 239 (2023). https:\/\/doi.org\/10.1038\/s41392-023-01502-8","journal-title":"Signal Transduct Target Ther"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1038\/s41586-021-03307-7","article-title":"J. The central role of DNA damage in the ageing process","volume":"592","author":"Schumacher B","year":"2021","unstructured":"Schumacher, B., Pothof, J., Vijg, J. & Hoeijmakers, J. H. J. The central role of DNA damage in the ageing process. Nature 592, 695\u2013703 (2021). https:\/\/doi.org\/10.1038\/s41586-021-03307-7","journal-title":"Nature"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"e46126","DOI":"10.1371\/journal.pone.0046126","article-title":"Inhibition of doxorubicin-induced senescence by PPARdelta activation agonists in cardiac muscle cells: cooperation between PPARdelta and Bcl6","volume":"7","author":"Altieri P","year":"2012","unstructured":"Altieri, P. et al. Inhibition of doxorubicin-induced senescence by PPARdelta activation agonists in cardiac muscle cells: cooperation between PPARdelta and Bcl6. PLoS One 7, e46126 (2012). https:\/\/doi.org\/10.1371\/journal.pone.0046126","journal-title":"PLoS One"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"3008","DOI":"10.1101\/gad.12.19.3008","article-title":"Premature senescence involving p53 and p16 is activated in response to constitutive MEK\/MAPK mitogenic signaling","volume":"12","author":"Lin AW","year":"1998","unstructured":"Lin, A. W. et al. Premature senescence involving p53 and p16 is activated in response to constitutive MEK\/MAPK mitogenic signaling. Genes Dev 12, 3008\u20133019 (1998). https:\/\/doi.org\/10.1101\/gad.12.19.3008","journal-title":"Genes Dev"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1038\/nm.4000","article-title":"Cellular senescence in aging and age-related disease: from mechanisms to therapy","volume":"21","author":"Childs BG","year":"2015","unstructured":"Childs, B. G., Durik, M., Baker, D. J. & van Deursen, J. M. Cellular senescence in aging and age-related disease: from mechanisms to therapy. Nat Med 21, 1424\u20131435 (2015). https:\/\/doi.org\/10.1038\/nm.4000","journal-title":"Nat Med"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"4430","DOI":"10.1158\/1078-0432.CCR-23-1055","article-title":"Circulating microRNAs and Cytokines as Prognostic Biomarkers for Doxorubicin-Induced Cardiac Injury and for Evaluating the Effectiveness of an Exercise Intervention","volume":"29","author":"Jeyabal P","year":"2023","unstructured":"Jeyabal, P. et al. Circulating microRNAs and Cytokines as Prognostic Biomarkers for Doxorubicin-Induced Cardiac Injury and for Evaluating the Effectiveness of an Exercise Intervention. Clin Cancer Res 29, 4430\u20134440 (2023). https:\/\/doi.org\/10.1158\/1078-0432.CCR-23-1055","journal-title":"Clin Cancer Res"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3390\/cancers13112740","article-title":"Exercise Inhibits Doxorubicin-Induced Damage to Cardiac Vessels and Activation of Hippo\/YAP-Mediated Apoptosis","author":"Tao RH","year":"2021","unstructured":"Tao, R. H., Kobayashi, M., Yang, Y. & Kleinerman, E. S. Exercise Inhibits Doxorubicin-Induced Damage to Cardiac Vessels and Activation of Hippo\/YAP-Mediated Apoptosis. Cancers (Basel) 13 (2021). https:\/\/doi.org\/10.3390\/cancers13112740","journal-title":"Cancers (Basel)"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"7572","DOI":"10.1002\/cam4.4283","article-title":"Exercise intervention decreases acute and late doxorubicin-induced cardiotoxicity","volume":"10","author":"Wang F","year":"2021","unstructured":"Wang, F., Chandra, J. & Kleinerman, E. S. Exercise intervention decreases acute and late doxorubicin-induced cardiotoxicity. Cancer Med 10, 7572\u20137584 (2021). https:\/\/doi.org\/10.1002\/cam4.4283","journal-title":"Cancer Med"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1097\/MPH.0000000000001112","article-title":"Aerobic Exercise During Early Murine Doxorubicin Exposure Mitigates Cardiac Toxicity","volume":"40","author":"Wang F","year":"2018","unstructured":"Wang, F. et al. Aerobic Exercise During Early Murine Doxorubicin Exposure Mitigates Cardiac Toxicity. J Pediatr Hematol Oncol 40, 208\u2013215 (2018). https:\/\/doi.org\/10.1097\/MPH.0000000000001112","journal-title":"J Pediatr Hematol Oncol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/j.devcel.2014.11.012","article-title":"An essential role for senescent cells in optimal wound healing through secretion of PDGF-AA","volume":"31","author":"Demaria M","year":"2014","unstructured":"Demaria, M. et al. An essential role for senescent cells in optimal wound healing through secretion of PDGF-AA. Dev Cell 31, 722\u2013733 (2014). https:\/\/doi.org\/10.1016\/j.devcel.2014.11.012","journal-title":"Dev Cell"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1083\/jcb.201206006","article-title":"p53-dependent release of Alarmin HMGB1 is a central mediator of senescent phenotypes","volume":"201","author":"Davalos AR","year":"2013","unstructured":"Davalos, A. R. et al. p53-dependent release of Alarmin HMGB1 is a central mediator of senescent phenotypes. J Cell Biol 201, 613\u2013629 (2013). https:\/\/doi.org\/10.1083\/jcb.201206006","journal-title":"J Cell Biol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/s41514-023-00102-8","article-title":"Aging reduces calreticulin expression and alters spontaneous calcium signals in astrocytic endfeet of the mouse dorsolateral striatum","volume":"9","author":"Zarate SM","year":"2023","unstructured":"Zarate, S. M., Huntington, T. E., Bagher, P. & Srinivasan, R. Aging reduces calreticulin expression and alters spontaneous calcium signals in astrocytic endfeet of the mouse dorsolateral striatum. NPJ Aging 9, 5 (2023). https:\/\/doi.org\/10.1038\/s41514-023-00102-8","journal-title":"NPJ Aging"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1126\/science.ade4961","article-title":"Aging impairs the neurovascular interface in the heart","volume":"381","author":"Wagner JUG","year":"2023","unstructured":"Wagner, J. U. G. et al. Aging impairs the neurovascular interface in the heart. Science 381, 897\u2013906 (2023). https:\/\/doi.org\/10.1126\/science.ade4961","journal-title":"Science"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.bbamem.2013.07.011","article-title":"The physiological role of cardiac cytoskeleton and its alterations in heart failure","volume":"1838","author":"Sequeira V","year":"2014","unstructured":"Sequeira, V., Nijenkamp, L. L., Regan, J. A. & van der Velden, J. The physiological role of cardiac cytoskeleton and its alterations in heart failure. Biochim Biophys Acta 1838, 700\u2013722 (2014). https:\/\/doi.org\/10.1016\/j.bbamem.2013.07.011","journal-title":"Biochim Biophys Acta"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"4086","DOI":"10.1038\/s41467-021-24049-0","article-title":"Molecular-scale visualization of sarcomere contraction within native cardiomyocytes","volume":"12","author":"Burbaum L","year":"2021","unstructured":"Burbaum, L. et al. Molecular-scale visualization of sarcomere contraction within native cardiomyocytes. Nat Commun 12, 4086 (2021). https:\/\/doi.org\/10.1038\/s41467-021-24049-0","journal-title":"Nat Commun"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1038\/s41467-018-04290-w","article-title":"Structural basis for cofilin binding and actin filament disassembly","volume":"9","author":"Tanaka K","year":"2018","unstructured":"Tanaka, K. et al. Structural basis for cofilin binding and actin filament disassembly. Nat Commun 9, 1860 (2018). https:\/\/doi.org\/10.1038\/s41467-018-04290-w","journal-title":"Nat Commun"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1016\/j.cub.2017.05.036","article-title":"Enhanced Depolymerization of Actin Filaments by ADF\/Cofilin and Monomer Funneling by Capping Protein Cooperate to Accelerate Barbed-End Growth","volume":"27","author":"Shekhar S","unstructured":"Shekhar, S. & Carlier, M. F. Enhanced Depolymerization of Actin Filaments by ADF\/Cofilin and Monomer Funneling by Capping Protein Cooperate to Accelerate Barbed-End Growth. Curr Biol 27, 1990\u20131998 e1995 (2017). https:\/\/doi.org\/10.1016\/j.cub.2017.05.036","journal-title":"Curr Biol"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"103527","DOI":"10.1016\/j.redox.2025.103527","article-title":"FNDC5\/irisin mitigates the cardiotoxic impacts of cancer chemotherapeutics by modulating ROS-dependent and -independent mechanisms","volume":"80","author":"Kumar M","year":"2025","unstructured":"Kumar, M. et al. FNDC5\/irisin mitigates the cardiotoxic impacts of cancer chemotherapeutics by modulating ROS-dependent and -independent mechanisms. Redox Biol 80, 103527 (2025). https:\/\/doi.org\/10.1016\/j.redox.2025.103527","journal-title":"Redox Biol"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"e022453","DOI":"10.1161\/JAHA.121.022453","article-title":"The Emerging Role of Irisin in Cardiovascular Diseases","volume":"10","author":"Fu J","year":"2021","unstructured":"Fu, J. et al. The Emerging Role of Irisin in Cardiovascular Diseases. J Am Heart Assoc 10, e022453 (2021). https:\/\/doi.org\/10.1161\/JAHA.121.022453","journal-title":"J Am Heart Assoc"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.136277","article-title":"Exercise hormone irisin mitigates endothelial barrier dysfunction and microvascular leakage-related diseases","volume":"5","author":"Bi J","year":"2020","unstructured":"Bi, J. et al. Exercise hormone irisin mitigates endothelial barrier dysfunction and microvascular leakage-related diseases. JCI Insight 5 (2020). https:\/\/doi.org\/10.1172\/jci.insight.136277","journal-title":"JCI Insight"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"4579","DOI":"10.1093\/eurheartj\/ehac431","article-title":"Exerkine fibronectin type-III domain-containing protein 5\/irisin-enriched extracellular vesicles delay vascular ageing by increasing SIRT6 stability","volume":"43","author":"Chi C","year":"2022","unstructured":"Chi, C. et al. Exerkine fibronectin type-III domain-containing protein 5\/irisin-enriched extracellular vesicles delay vascular ageing by increasing SIRT6 stability. Eur Heart J 43, 4579\u20134595 (2022). https:\/\/doi.org\/10.1093\/eurheartj\/ehac431","journal-title":"Eur Heart J"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"e13556","DOI":"10.1111\/acel.13556","article-title":"Fibronectin type III domain-containing 5 improves aging-related cardiac dysfunction in mice","volume":"21","author":"Hu C","year":"2022","unstructured":"Hu, C. et al. Fibronectin type III domain-containing 5 improves aging-related cardiac dysfunction in mice. Aging Cell 21, e13556 (2022). https:\/\/doi.org\/10.1111\/acel.13556","journal-title":"Aging Cell"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.jaccao.2023.03.012","article-title":"Evaluation of Senescence and Its Prevention in Doxorubicin-Induced Cardiotoxicity Using Dynamic Engineered Heart Tissues","volume":"5","author":"Linders AN","year":"2023","unstructured":"Linders, A. N. et al. Evaluation of Senescence and Its Prevention in Doxorubicin-Induced Cardiotoxicity Using Dynamic Engineered Heart Tissues. JACC CardioOncol 5, 298\u2013315 (2023). https:\/\/doi.org\/10.1016\/j.jaccao.2023.03.012","journal-title":"JACC CardioOncol"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1161\/CIRCULATIONAHA.124.071774","article-title":"Endothelial Transcription Factor EB Protects Against Doxorubicin-Induced Endothelial Toxicity and Cardiac Dysfunction","volume":"153","author":"Du W","year":"2026","unstructured":"Du, W. et al. Endothelial Transcription Factor EB Protects Against Doxorubicin-Induced Endothelial Toxicity and Cardiac Dysfunction. Circulation 153, 653\u2013672 (2026). https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.124.071774","journal-title":"Circulation"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"H1672","DOI":"10.1152\/ajpheart.00712.2025","article-title":"Cellular senescence mediates doxorubicin chemotherapy-induced vascular endothelial dysfunction: translational evidence of prevention with senolytic treatment","volume":"329","author":"Venkatasubramanian R","year":"2025","unstructured":"Venkatasubramanian, R. et al. Cellular senescence mediates doxorubicin chemotherapy-induced vascular endothelial dysfunction: translational evidence of prevention with senolytic treatment. Am J Physiol Heart Circ Physiol 329, H1672\u2013H1683 (2025). https:\/\/doi.org\/10.1152\/ajpheart.00712.2025","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"153597","DOI":"10.1016\/j.tox.2023.153597","article-title":"Irisin protects against doxorubicin-induced cardiotoxicity by improving AMPK-Nrf2 dependent mitochondrial fusion and strengthening endogenous anti-oxidant defense mechanisms","volume":"494","author":"Zhuo C","year":"2023","unstructured":"Zhuo, C. et al. Irisin protects against doxorubicin-induced cardiotoxicity by improving AMPK-Nrf2 dependent mitochondrial fusion and strengthening endogenous anti-oxidant defense mechanisms. Toxicology 494, 153597 (2023). https:\/\/doi.org\/10.1016\/j.tox.2023.153597","journal-title":"Toxicology"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/s41418-019-0372-z","article-title":"FNDC5 alleviates oxidative stress and cardiomyocyte apoptosis in doxorubicin-induced cardiotoxicity via activating AKT","volume":"27","author":"Zhang X","year":"2020","unstructured":"Zhang, X. et al. FNDC5 alleviates oxidative stress and cardiomyocyte apoptosis in doxorubicin-induced cardiotoxicity via activating AKT. Cell Death Differ 27, 540\u2013555 (2020). https:\/\/doi.org\/10.1038\/s41418-019-0372-z","journal-title":"Cell Death Differ"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.yjmcc.2015.07.015","article-title":"Irisin improves endothelial function in type 2 diabetes through reducing oxidative\/nitrative stresses","volume":"87","author":"Zhu D","year":"2015","unstructured":"Zhu, D. et al. Irisin improves endothelial function in type 2 diabetes through reducing oxidative\/nitrative stresses. J Mol Cell Cardiol 87, 138\u2013147 (2015). https:\/\/doi.org\/10.1016\/j.yjmcc.2015.07.015","journal-title":"J Mol Cell Cardiol"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"102120","DOI":"10.1016\/j.redox.2021.102120","article-title":"Irisin ameliorates doxorubicin-induced cardiac perivascular fibrosis through inhibiting endothelial-to-mesenchymal transition by regulating ROS accumulation and autophagy disorder in endothelial cells","volume":"46","author":"Pan JA","year":"2021","unstructured":"Pan, J. A. et al. Irisin ameliorates doxorubicin-induced cardiac perivascular fibrosis through inhibiting endothelial-to-mesenchymal transition by regulating ROS accumulation and autophagy disorder in endothelial cells. Redox Biol 46, 102120 (2021). https:\/\/doi.org\/10.1016\/j.redox.2021.102120","journal-title":"Redox Biol"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1089\/jayao.2018.0141","article-title":"Short-Term Changes in Cardiac Function in Osteosarcoma Patients Receiving Anthracyclines","volume":"8","author":"Gilchrist SC","year":"2019","unstructured":"Gilchrist, S. C. et al. Short-Term Changes in Cardiac Function in Osteosarcoma Patients Receiving Anthracyclines. J Adolesc Young Adult Oncol 8, 385\u2013386 (2019). https:\/\/doi.org\/10.1089\/jayao.2018.0141","journal-title":"J Adolesc Young Adult Oncol"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1093\/eschf\/xvag143","article-title":"Early anthracycline cardiotoxicity in adolescents and young adults with sarcoma: a prospective echocardiographic study","volume":"13","author":"Koutroumpakis E","year":"2026","unstructured":"Koutroumpakis, E. et al. Early anthracycline cardiotoxicity in adolescents and young adults with sarcoma: a prospective echocardiographic study. ESC Heart Fail 13 (2026). https:\/\/doi.org\/10.1093\/eschf\/xvag143","journal-title":"ESC Heart Fail"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1158\/0008-5472.can-03-1816","article-title":"Imaging tri-fusion multimodality reporter gene expression in living subjects","volume":"64","author":"Ray P","year":"2004","unstructured":"Ray, P., De, A., Min, J. J., Tsien, R. Y. & Gambhir, S. S. Imaging tri-fusion multimodality reporter gene expression in living subjects. Cancer Res 64, 1323\u20131330 (2004). https:\/\/doi.org\/10.1158\/0008-5472.can-03-1816","journal-title":"Cancer Res"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/nature10600","article-title":"Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders","volume":"479","author":"Baker DJ","year":"2011","unstructured":"Baker, D. J. et al. Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nature 479, 232\u2013236 (2011). https:\/\/doi.org\/10.1038\/nature10600","journal-title":"Nature"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.cell.2012.12.010","article-title":"Monitoring tumorigenesis and senescence in vivo with a p16(INK4a)-luciferase model","volume":"152","author":"Burd CE","year":"2013","unstructured":"Burd, C. E. et al. Monitoring tumorigenesis and senescence in vivo with a p16(INK4a)-luciferase model. Cell 152, 340\u2013351 (2013). https:\/\/doi.org\/10.1016\/j.cell.2012.12.010","journal-title":"Cell"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1083\/jcb.200904105","article-title":"Real-time in vivo imaging of p16Ink4a reveals cross talk with p53","volume":"186","author":"Yamakoshi K","year":"2009","unstructured":"Yamakoshi, K. et al. Real-time in vivo imaging of p16Ink4a reveals cross talk with p53. J Cell Biol 186, 393\u2013407 (2009). https:\/\/doi.org\/10.1083\/jcb.200904105","journal-title":"J Cell Biol"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"947604","DOI":"10.3389\/fonc.2022.947604","article-title":"Doxorubicin-induced cardiotoxicity is mediated by neutrophils through release of neutrophil elastase","volume":"12","author":"Bhagat A","year":"2022","unstructured":"Bhagat, A. et al. Doxorubicin-induced cardiotoxicity is mediated by neutrophils through release of neutrophil elastase. Front Oncol 12, 947604 (2022). https:\/\/doi.org\/10.3389\/fonc.2022.947604","journal-title":"Front Oncol"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-10910107\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-10910107\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T21:54:53Z","timestamp":1794606893000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-10910107\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,29]]},"references-count":52,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-10910107\/v1","relation":{},"subject":[],"published":{"date-parts":[[2026,9,29]]},"subtype":"preprint"}}